28
Views
1
CrossRef citations to date
0
Altmetric
Patent Evaluation

Aminopyridines as protein kinase Cθ inhibitors

Boehringer Ingelheim: US20060217417

Pages 583-586 | Published online: 02 May 2007
 

Abstract

There is a continued interest in pursuing protein kinase C (PKC)θ as a potential novel therapeutic target. A recently published patent application from Boeh- ringer Ingelheim discloses pyridine derivatives as PKCθ inhibitors, many of which possess inhibitory activity down to low nM. These compounds display selective inhibition profiles over other kinases.

Patent Details

  • Title Pyridine derivatives useful as inhibitors of PKCτ.

  • Assignee Boehringer Ingelheim International GmbH.

  • Inventors Brunette SR, Kim JM, Lemieux RM, Tschantz MA.

  • Priority date 27/03/06.

  • Filing date 27/03/06.

  • Publication date 28/09/06.

  • Publication no. US20060217417.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.